Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
Diabetic nephropathy is a leading cause of end-stage renal disease, which is increasing in incidence worldwide, despite intensive treatment approaches such as glycemic and blood pressure control in patients with diabetes mellitus. New therapeutic strategies are needed to prevent the onset of diabeti...
Saved in:
Main Authors: | Shinji Kume, Takashi Uzu, Keiji Isshiki, Daisuke Koya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/879523 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy
by: Kosuke Yamahara, et al.
Published: (2013-01-01) -
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
by: M. C. Thomas, et al.
Published: (2012-01-01) -
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01) -
Effect of Pesticides on Peroxisome Proliferator-Activated Receptors (PPARs) and Their Association with Obesity and Diabetes
by: J. Hernández-Valdez, et al.
Published: (2023-01-01)